
Boomers Should Not ...


| Price and Volume | |
|---|---|
| Recent Price | 2.02 |
| 52 Week High | 2.15 |
| 52 Week Low | 1.32 |
| Avg. Daily Vol. (Mil) | 0.07 |
| Beta (3 year) | 1.05 |
| Share Related Items | |
| Mkt Cap (Mil) | 62.75 |
| Shares Out (Mil) | 31.06 |
| Float (Mil) | 27.73 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 9.30 |
| Current Ratio | 13.00 |
| LT Debt/ Equity | 0.29 |
| Total Debt / Equity | 0.29 |
| Valuation Ratios | |
| Price Earnings | 50.50 |
| Price/Sales | 0.78 |
| Price/Book | 0.81 |
| Price/Cash Flow | 6.30 |
| Per Share Data | |
| Earnings | 0.04 |
| Sales | 2.60 |
| Book Value | 2.49 |
| Cash Flow | 0.32 |
| Business Summary | |
|---|---|
| Theragenics Corporation is a medical device Company serving the surgical products and cancer treatment markets. It operates in two business segments namely the surgical products segment and the brachytherapy seed segment. | |
| General Information | |
| 5203 Bristol Industrial Way
Buford, GA 30518 |
|
| www.theragenics.com | |
| Industry : Health Services | |
| Sector: Health Care | |
| Employees: 534 | |
| CEO: M. Christine Jacobs | |
| Short Interest | |
| Current Month (Mil) | 0.02 |
| Previous Month (Mil) | 0.02 |
| Short Interest Ratio (Days) | 1.30 |
| Management Effectiveness | |
| Return on Equity | 2.70 |
| Return on Assets | 2.00 |
| Return on Investments | 2.10 |
| Profitability | |
| Gross Margin | 41.40 |
| EBIT Margin | 2.90 |
| Profit Margin | 2.60 |